SoCal Savvy: Testing Savvy Caregiver in a Racially and Ethnically Diverse Sample in Southern California (SoCalSavvy)

November 1, 2022 updated by: Maria P. Aranda, University of Southern California

SoCal Savvy: Testing Savvy Caregiver in a Racially and Ethnically Diverse Sample in

The investigators will conduct a hybrid efficacy-effectiveness trial intended to address these gaps by testing the efficacy-effectiveness of two multi-family group interventions, and on 250 English-speaking adults: Savvy Caregiver Express™ (3-session, newly piloted in Los Angeles County for feasibility) and Savvy Caregiver Program (original 6-session evidenced-based intervention), across post-intervention, 3- and 6-months.

Study Overview

Detailed Description

A number of epidemiological studies, systematic reviews, and consensus reports highlight the importance of non-pharmacological, sociobehavioural interventions to address the health, psychological, and social effects of caregiving for persons living with dementia, and the need for tangible information and resources.

The investigators will conduct a hybrid efficacy-effectiveness trial intended to address these gaps by testing the efficacy-effectiveness of two multi-family group interventions, and on 250 English-speaking adults: Savvy Caregiver Express™ (3-session, newly piloted in Los Angeles County for feasibility) and Savvy Caregiver Program (original 6-session evidenced-based intervention), across post-intervention, 3- and 6-months. It is hypothesized that no differences (comparable effects) between the programs in their efficacy/effectiveness and moderating conditions.

Focus groups (~25 participants) will be conducted to ascertain program acceptability and satisfaction.

The analyses will include a multiple linear mixed-effects modeling for our trial outcomes, and thematic analyses for our focus group interview data.

Study Type

Interventional

Enrollment (Anticipated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • Los Angeles, California, United States, 90015
        • Recruiting
        • University of Southern California
        • Contact:
          • Maria P Aranda, PhD
          • Phone Number: 213-740-1887
          • Email: aranda@usc.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • English- speaking women and men age 18 or older who care for or provide assistance to someone with dementia

Exclusion Criteria:

  • Caregivers who have sensory or physical conditions that interfere with participation in an on-site, group-administered activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Savvy Caregiver Program
Savvy Caregiver Program, 6 weekly sessions, group treatment, addressing educational, informational, and psychosocial issues and community resources.
Informational and educational group-mediated program for family members caring for a person living with dementia; 3 sessions.
Active Comparator: Savvy Express
Savvy Express, 3 weekly sessions, group treatment, addressing educational, informational, and psychosocial issues and community resources.
Informational and educational group-mediated program for family members caring for a person living with dementia; 6 sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: up to 7 months
caregiver depressive symptoms
up to 7 months
Generalized Anxiety Disorder (GAD-7)
Time Frame: up to 7 months
caregiver anxiety symptoms
up to 7 months
Revised Memory and Behavior Problems Checklist (RMBPC)
Time Frame: up to 7 months
caregiver reactivity to family member's memory/behavior problems
up to 7 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver Competence Scales
Time Frame: up to 7 months
measures caregiver skills, mastery, competence, management of the situation based on the Caregiver Competence, Management and Meaning Scales
up to 7 months
Medical Outcomes Study Social Support Survey (MOS)
Time Frame: up to 7 months
Measures caregiver social support using the MOS scale
up to 7 months
Intent to Institutionalize
Time Frame: up to 7 months
TA one-item measure that assesses if the caregiver intends to institutionalize the family member in the next 6 months
up to 7 months
Family Members Activities of Daily Living (ADL)
Time Frame: up to 7 months
measures family member's activities of daily living using the Katz ADL scale
up to 7 months
Family Members Instrumental Activities of Daily Living (IADL)
Time Frame: up to 7 months
measures family member's activities of daily living using the Lawton IDL scale
up to 7 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver Satisfaction
Time Frame: up to 7 months
This is a measure developed for this specific study to ascertain the study participant's satisfaction with the intervention itself.
up to 7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2020

Primary Completion (Anticipated)

June 30, 2024

Study Completion (Anticipated)

June 30, 2024

Study Registration Dates

First Submitted

June 2, 2020

First Submitted That Met QC Criteria

June 4, 2020

First Posted (Actual)

June 9, 2020

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 5356000538

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Distress

Clinical Trials on Group sessions over 6 weeks

3
Subscribe